BTAI - BioXcel Therapeutics GAAP EPS of -$0.76 beats by $0.15 revenue of $0.38M misses by $0.36M
2024-03-12 07:02:27 ET
More on BioXcel Therapeutics
- UBS cuts BioXcel to neutral; cites regulatory issues, financing
- BioXcel Therapeutics announces termination of proposed public offering
- Seeking Alpha’s Quant Rating on BioXcel Therapeutics
- Historical earnings data for BioXcel Therapeutics
- Financial information for BioXcel Therapeutics